Pengnam, S.; Charoensuksai, P.; Yingyongnarongkul, B.-e.; Saeeng, R.; Uludağ, H.; Patrojanasophon, P.; Opanasopit, P.; Plianwong, S.
siRNA Targeting Mcl-1 Potentiates the Anticancer Activity of Andrographolide Nanosuspensions via Apoptosis in Breast Cancer Cells. Pharmaceutics 2022, 14, 1196.
https://doi.org/10.3390/pharmaceutics14061196
AMA Style
Pengnam S, Charoensuksai P, Yingyongnarongkul B-e, Saeeng R, Uludağ H, Patrojanasophon P, Opanasopit P, Plianwong S.
siRNA Targeting Mcl-1 Potentiates the Anticancer Activity of Andrographolide Nanosuspensions via Apoptosis in Breast Cancer Cells. Pharmaceutics. 2022; 14(6):1196.
https://doi.org/10.3390/pharmaceutics14061196
Chicago/Turabian Style
Pengnam, Supusson, Purin Charoensuksai, Boon-ek Yingyongnarongkul, Rungnapha Saeeng, Hasan Uludağ, Prasopchai Patrojanasophon, Praneet Opanasopit, and Samarwadee Plianwong.
2022. "siRNA Targeting Mcl-1 Potentiates the Anticancer Activity of Andrographolide Nanosuspensions via Apoptosis in Breast Cancer Cells" Pharmaceutics 14, no. 6: 1196.
https://doi.org/10.3390/pharmaceutics14061196
APA Style
Pengnam, S., Charoensuksai, P., Yingyongnarongkul, B. -e., Saeeng, R., Uludağ, H., Patrojanasophon, P., Opanasopit, P., & Plianwong, S.
(2022). siRNA Targeting Mcl-1 Potentiates the Anticancer Activity of Andrographolide Nanosuspensions via Apoptosis in Breast Cancer Cells. Pharmaceutics, 14(6), 1196.
https://doi.org/10.3390/pharmaceutics14061196
